Claude designs 35,000 antibodies in a month as Anthropic pushes into drug discovery
minchoi · x · 2026-10-28
Anthropic announced deep research partnerships with six drug development organizations and its own early drug discovery efforts. Key numbers cited:
- 35,000 antibody designs generated with Claude in about a month
- 10x more receptors on cancer-fighting immune cells in lab tests
- 89% less human review time on drug manufacturing paperwork
- Anthropic acquired a one-person biotech that used Claude to go from idea to promising mouse results in under 18 months
The post signals life sciences as a major strategic focus for Anthropic's AI4Science ambitions.
More from Companies & People
- IBM TechXchange: Three Big Challenges of Adopting AI Agents in the Enterprise — craigmullins · 2026-10-29
- 80% of Google Cloud Customers Now Run Production AI Workloads — craigmullins · 2026-10-29
- AI Horizons Forum open for applications until Nov 30, aiming to onboard newcomers into AI safety — ben_j_todd · 2026-10-29
- OpenAI's Berlin DevDay: Dots coming to Europe in weeks, German Codex users up 20x — The Decoder · 2026-10-29
- X users contrast Anthropic's quiet professionalism with other AI labs' public drama — brandon_galang · 2026-10-29
- Will Anthropic's AI find cures? Scientist says the bottleneck is funding, not science — anshulkundaje · 2026-10-29